Grants for Private institutions of higher education - Health

The Tier 3 Clinical/Translational Research Grant is designed for advanced research projects that are concurrently applying for or have funding from federal or industry sources. This grant requires published preliminary data and offers up to $500,000 over three years with an additional two-year no-cost extension.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), theNCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in community cancer prevention, intervention, and treatment research. Special emphasis is placed on training of clinical scientists whose career goal is to meet the needs of underserved or underrepresent ed communities for access to clinical care and participation in clinical research. The NOFO will allow the appointment ofScholars proposing to serve as the lead investigator of an independent community-based clinical trial; or proposing a separate ancillary study to an existing prevention, screening or control clinical trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of underserved or underrepresented communitiesin cancer clinical research, as part of their research and career development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is expected to be published in April 2024 with an expected application due date in June 2024. TheNOFO will utilize theK12 activity code for Clinical Scientist Institutional Career Development Program Awards. Details of the planned NOFO are provided below.

Utilizing CMP funds from the federal CMS, long-term care facilities will be able to implement as few as one (1) and as many as six (6) projects for their Long-Term Care facility. In an effort to support the maintenance of cognitive and mobility skills, the Illinois Department of Public Health, Office of Healthcare Regulation (OHCR) announces an opportunity for certified facilities to submit applications for projects that must provide the residents of long term care facilities with a program or project deliverable that meaningfully improves the quality of life or quality of care for residents in the facility. These projects should deliver direct improvements to quality of life, direct improvements to quality of care, alternatives to pharmacological interventions, alternative behavioral management, training programs and implementation.

This funding opportunity provides financial support to organizations in Ohio looking to establish new Child Advocacy Centers that focus on preventing child abuse and neglect through collaborative, child-friendly services.

This funding opportunity is designed for U.S. academic institutions with specialized mining programs to develop innovative technologies and research that improve the safety and effectiveness of underground mine evacuations during emergencies.

The United States Agency for International Development in Southern Africa (USAID/SouthernAfrica) is seeking Concept Papers from qualified entities to implement an activity entitledHealth Financing and Public Financial Management Systems Strengthening Activity in SouthAfrica. Eligibility for this award is not restricted. The authority for the Notice of FundingOpportunity (NOFO) is found in the Foreign Assistance Act of 1961, as amended.Subject to funding availability and at the discretion of the Agency, USAID intends to provide upto $30 million in total USAID funding over a five (5) year period through a CooperativeAgreement with the selected applicant. Eligible organizations interested in submitting a ConceptPaper are encouraged to read this NOFO thoroughly to understand the type of project sought(Section A), the application submission requirements (Sections C and D), and the evaluationprocess and merit review criteria (Section E). To be eligible for award, the applicant mustprovide all information required in this NOFO and meet eligibility standards in Section C.Concepts must be received by the date and time indicated at the top of this cover letter. Notethat USAID is not accepting full applications at this time - only Concept Papers.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for large single or multisite clinical trials within the mission area of the institute. The NOFO is expected to be published in Spring 2024 with an expected application due date in Summer 2024. Only New, Resubmission and Revision applications will be eligible. This NOFO will utilize the UG3/UH3 phased cooperative agreement activity code. A UG3 milestone plan is required. Details of the planned NOFO are provided below.

This funding opportunity supports healthcare organizations in developing innovative quality improvement projects to enhance migraine management and patient care in emergency departments across the United States.

This funding opportunity supports Kuwait-based non-profits, educational institutions, and individuals in creating cultural and educational programs that strengthen ties between the U.S. and Kuwait, with a focus on diversity, inclusion, and shared challenges.

This funding opportunity supports research projects that develop and implement community-focused interventions to improve vision health outcomes and address disparities among underserved populations.

The Artistic Legacy Grant (ALG), funded by the San Francisco Arts Commission, offers $10,000 to $100,000 for a 3-year period to support and celebrate an artist who has significantly contributed to San Francisco's arts and culture for at least 25 years, with funds to be used for professional development, artistic planning, sabbaticals, and other related costs.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine to treat neurological diseases, aiming to advance health and wellness for residents through innovative, collaborative projects.

This funding opportunity supports research institutions and organizations in studying biological markers of cognitive decline and dementia in aging individuals with Autism Spectrum Disorders, aiming to improve understanding and assessment of these conditions.

This funding opportunity provides financial support to nonprofit organizations, government entities, and educational institutions in Ohio to enhance and sustain trauma-informed care initiatives across six designated regions.

This funding opportunity provides financial support for short-term projects that enhance local governance, infrastructure, education, and public safety in U.S. territories and freely associated states.

This funding opportunity is designed for healthcare institutions and organizations in the U.S. to improve the management and outcomes of migraine patients in emergency departments.

Wastewater Based Epidemiology involves analyzing the chemical and biological components present in wastewater to gather information about the health and behavior of a population. Localities have used it to monitor drug consumption patterns in their communities and understand local drug usage trends. It holds promise for monitoring the emergence and geographic distribution of novel substances often referred to as emerging threats. In FY2023, the United States Government funded pilot WBE drug projects that collected wastewater samples in over 70 United States communities representing tens of millions of Americans. The samples were analyzed for parent drugs, such as fentanyl and methamphetamine, and metabolites. Researchers shared results with participating sampled communities, local and state partners, and to a limited extent, the government sponsors.

This funding opportunity provides financial support to organizations working to combat domestic violence, dating violence, sexual assault, and stalking in rural communities across the U.S.

This funding opportunity is designed to support the establishment of collaborative research centers that enhance the study and treatment of bone, muscle, and orthopaedic conditions through shared resources and multidisciplinary approaches.

The Pfizer Sickle Cell Disease (SCD) Fellowship Grant is designed to bolster the number of fellowship programs focused on hematologists who specialize in the treatment of adults with sickle cell disease. This initiative is part of Pfizer Global Medical Grants' broader strategy to support healthcare community-led initiatives that enhance patient outcomes in critical areas of unmet medical need, aligning with Pfizer’s own medical and scientific strategies. The grant aims to enhance the quality of care for sickle cell patients by funding institutions that provide comprehensive training and research opportunities in the field. Specifically, the program supports both established and newly developed fellowship programs that include a robust curriculum in clinical practice, independent research, and education to deepen the scientific understanding of SCD. The fellowship is structured to foster an environment of expert mentorship and significant independent research opportunities. Research activities encouraged under this grant include observational studies and outcomes research that focus on the disease itself, screening tools, and their impact on patient health improvement. Grant funding is set at a maximum of $100,000 for a one-year fellowship, aiming to cover direct costs associated with the fellow’s training and research but explicitly excluding overhead or indirect costs. This financial support underlines Pfizer's commitment to advancing healthcare by investing directly in the development of professionals who are dedicated to improving patient outcomes in the field of sickle cell disease. Key to the grant’s operational framework is compliance with stringent regulatory requirements, including the U.S. Physician Payments Sunshine Act. This act mandates detailed reporting of all transfers of value to ensure transparency and maintain public trust in healthcare practices. The fellowship’s funding structure is designed to be transparent, with specific provisions to prevent any of the funds from benefiting Pfizer's business interests directly or indirectly. Overall, the Pfizer SCD Fellowship embodies a strategic effort to cultivate talent and advance knowledge in a critical area of healthcare, ensuring that the supported programs maintain high standards of integrity and contribute significantly to the field's body of knowledge and patient care practices.